🔎 Trials Near Me

መነሻ › የጡንቻ ካንሰር › North Carolina › Durham

በDurham፣ NC ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 64 ጥናቶች በDurham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

The Vanguard Study: Testing a New Way to Screen for Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Durham VA Medical Center, Durham
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ45 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06995898

A Study of PHST001 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Duke University, Durham
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Duke Cancer Network, Durham
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Durham VA Medical Center, Durham
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ18 እስከ 45 · ሴቶች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06369285

Radiation Therapy and Thymus Function in Young Women With Breast Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Duke Cancer Center, Durham
እድሜ ከ18 እስከ 50 · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07725172

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Duke Cancer Center, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06120283

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05440929

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07007559

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Trial Site, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07085767

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Duke University Medical Center, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of North Carolina Medical Center, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of North Carolina Medical Center, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07287098

Identifying Patterns in the Breath of Individuals With Breast Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Duke University Medical Cente, Durham
እድሜ ከ40 እስከ 74 · ሴቶች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06512350

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07340541

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07685938

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ20 እስከ 74 · ሴቶች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07214610

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT03424005

A Phase 1/1b Study of IAM1363 in HER2 Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06253871

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Duke University, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT05846789

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 50 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06902311

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Duke University Medical Center, Durham
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
  • University of North Carolina-Hillsborough Campus, Hillsborough · 13 ማይል ርቀት
እድሜ ከ18 እስከ 60 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05879926

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07025785

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06533826

Optimizing Surgical Decisions in Young Adults With Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • Duke Cancer Institute, Durham
እድሜ ከ18 እስከ 44 · ሴቶች · የተሻሻለው በ19 ኦገስ 2026 · NCT06275126

A Novel Approach Utilizing Organ Specific Age Proteomics

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ22 እስከ 66 · ሴቶች · የተሻሻለው በ18 ኦገስ 2026 · NCT06789653

Weight Management After Cancer for Survivors in Rural Communities

ተሳታዮችን በመፈለግ ላይ
  • Duke University Medical Center, Durham
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ13 ኦገስ 2026 · NCT07426952

Behavioral Pain Intervention for Older Cancer Patients

ተሳታዮችን በመፈለግ ላይ
  • Duke Cancer Network, Durham
እድሜ 55 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ12 ኦገስ 2026 · NCT07300995

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06926868

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

ተሳታዮችን በመፈለግ ላይ
  • Duke University/Duke Cancer Center, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT07140172

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Duke University Medical Center, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06176261

Planning Grant for TOPS for Breast Cancer Survivors

ተሳታዮችን በመፈለግ ላይ
  • Duke University, Durham
እድሜ ከ21 እስከ 90 · ሴቶች · የተሻሻለው በ5 ኦገስ 2026 · NCT06658912

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ጁላይ 2026 · NCT06347068

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

ተሳታዮችን በመፈለግ ላይ
  • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT06896162

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

ተሳታዮችን በመፈለግ ላይ
  • Duke Cancer Institute (Data collection only), Durham
  • Duke Cancer Institute (Data collection only), Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2026 · NCT07335354

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT01000883

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Duke University Medical Center, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT05696626

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT05029999

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
  • The University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁን 2026 · NCT07225114

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ20 እስከ 90 · ሴቶች · የተሻሻለው በ2 ጁን 2026 · NCT06878547

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 65 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ26 ሜይ 2026 · NCT05472792

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)

ተሳታዮችን በመፈለግ ላይ
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT06855654

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ6 ሜይ 2026 · NCT06727773

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ኤፕሪ 2026 · NCT04468061

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT07276880

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT07069595

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

ተሳታዮችን በመፈለግ ላይ
  • Duke University, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኤፕሪ 2026 · NCT06896474

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Duke Cancer Center/ DUMC, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT05735080

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ማርች 2026 · NCT06610539

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT06099769

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Duke Cancer Institute, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • UNC Cancer Hospital, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ5 ፌብሩ 2026 · NCT07389967

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA

ተሳታዮችን በመፈለግ ላይ
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጃንዩ 2026 · NCT03769415

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

ተሳታዮችን በመፈለግ ላይ
  • Duke Cancer Institute, Durham
እድሜ ከ18 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ28 ጃንዩ 2026 · NCT06371768

Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise

ተሳታዮችን በመፈለግ ላይ
  • Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጃንዩ 2026 · NCT07313306

BREAST Choice Decision Tool R21 - AIM2

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • The University of North Carolina, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኖቬም 2025 · NCT06817226

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • Duke University, Durham
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኖቬም 2025 · NCT06795529

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Chapel Hill · 10 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

UNC Pleural Fluid Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኦክቶ 2025 · NCT05620329

በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች

በDurham ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።